Featured Research

from universities, journals, and other organizations

Regular Paracetamol Use Could Reduce Ovarian Cancer Risk By Almost A Third

Date:
July 6, 2006
Source:
Blackwell Publishing Ltd.
Summary:
Regular paracetamol use could reduce ovarian cancer by up to 30 percent, according to Dr. Stefanos Bonovas from Athens University and the Greek Ministry of Health. The researchers carried out a sophisticated meta-analysis of the results of eight major studies on 4,405 women in the UK, USA and Denmark. They concluded that the findings could have important public health implications for this disease, which has a high mortality rate -- due to ineffective screening and limited treatment success in the later stages.

Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third, according to a detailed analysis in the July issue of British Journal of Clinical Pharmacology.

Related Articles


A research team from Athens University found that the risk fell by up to 30 per cent when they analysed the results of major studies carried out on more than 746,000 women over a six-year period.

4,405 of the women in the eight major studies – from the USA, UK and Denmark – had ovarian cancer.

The team looked at all studies covering paracetamol and ovarian cancer from 1966 to 2004. These were then scrutinised using sophisticated meta-analysis techniques.

"Meta-analysis involves doing a large amount of research into what has been published, summarising the results and combining them using statistical methods" explains lead researcher Dr Stefanos Bonovas from the Greek Ministry of Health. "Analysing a wide range studies can often throw new light on a problem and raise new research questions.

"In this case our analysis of eight major studies – covering nearly three-quarters of a million women - revealed a strong correlation between paracetamol use and a reduced risk of ovarian cancer."

Seven of the studies looked at the links between paracetamol use and the incidence of ovarian cancer and the largest study looked at the link between paracetamol use and ovarian cancer deaths.

The researchers used a working definition of "regular use" as the highest frequency of drug use reported in the individual studies. This definition varied slightly between studies. In the largest study – which covered more than a third of the women diagnosed with ovarian cancer – it was defined as more than 30 tablets in the month before the study started.

"Ovarian cancer remains the most fatal gynaecological malignancy" says Dr Bonovas. "Its high mortality rate – mainly due to a combination of ineffective screening and the limited success of therapies for advanced disease - makes ovarian cancer a major health concern.

"Strategies that focus on prevention may therefore provide the most rational approach for reducing deaths from this form of cancer.

"Because paracetamol is so widely used, a link with a decreased risk of ovarian cancer could have important public health implications."

The authors believe that further research among women with a high risk of developing ovarian cancer would provide further clues to the drug's protective qualities.

"The risks of long-term paracetamol use - including liver and chronic kidney failure – may outweigh the potential benefits of preventing ovarian cancer in low-risk cases" concludes Dr Bonovas.

"However we believe that a randomised trial in women with a high risk of developing the disease might be appropriate. Further research is also needed into how this protective mechanism actually works.

The authors stress that they are not suggesting that women adopt this possible method of risk prevention at this stage.

"But we do feel that our study highlights the need for further research into this highly important link between a simple over-the-counter medicine and a very aggressive form of cancer" says Dr Bonovas.

Dr Bonovas works for the Department of Epidemiological Surveillance and Intervention at the Greek Ministry of Health's Hellenic Centre for Infectious Diseases Control and carries out his research at Athens University.

This study was carried out in association with University researcher Dr Kalitsa Filioussi, under the supervision of Dr Nikolaos M Sitaras, Associate Professor of Medicine in the Department of Pharmacology.


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "Regular Paracetamol Use Could Reduce Ovarian Cancer Risk By Almost A Third." ScienceDaily. ScienceDaily, 6 July 2006. <www.sciencedaily.com/releases/2006/07/060706175320.htm>.
Blackwell Publishing Ltd.. (2006, July 6). Regular Paracetamol Use Could Reduce Ovarian Cancer Risk By Almost A Third. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2006/07/060706175320.htm
Blackwell Publishing Ltd.. "Regular Paracetamol Use Could Reduce Ovarian Cancer Risk By Almost A Third." ScienceDaily. www.sciencedaily.com/releases/2006/07/060706175320.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins